Canlyniadau Chwilio - Han-Zhang, Han

The prevalence and prognostic value of KRAS co‐mutation subtypes in Chinese advanced non‐small cell lung cancer patients gan Cai, Dongjing, Hu, Chengping, Li, Li, Deng, Shichao, Yang, Jing, Han‐Zhang, Han, Li, Min

Cael y testun llawn Cael y testun llawn Cael y testun llawn

An EGFR-Amplified Cervical Squamous Cell Carcinoma Patient with Pulmonary Metastasis Benefits from Afatinib: A Case Report gan Chen, Qian, Huang, Yihua, Shao, Lin, Han-Zhang, Han, Yang, Fan, Wang, Yang, Liu, Jing, Gan, Jiadi

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report gan Zhou, Li, Ren, Yifeng, Wang, Xia, Miao, Dongliu, Lizaso, Analyn, Li, Haiyan, Han-Zhang, Han, Qian, Jun, Yang, Hui

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Exceptional Response of Cryoablation Followed by Pembrolizumab in a Patient with Metastatic Cervical Carcinosarcoma with High Tumor Mutational Burden: A Case Report gan Zhu, Baorang, Liu, Ying, Li, Jing, Diao, Liyan, Shao, Lin, Han‐Zhang, Han, Zhang, Lu, Kang, Qiaolin, Yang, Wuwei

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis gan He, Yiping, Ma, Xiaoji, Chen, Ke, Liu, Fangqi, Cai, Sanjun, Han-Zhang, Han, Hou, Ting, Xiang, Jianxing, Peng, Junjie

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Clinicopathologic features and genomic analysis of pulmonary blastomatoid carcinosarcoma gan Zhao, Jikai, Xiang, Chan, Zhao, Ruiying, Guo, Ping, Zheng, Jingjing, Han-Zhang, Han, Yu, Keke, Zhang, Jie, Han, Yuchen

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Maximum allele frequency observed in plasma: A potential indicator of liquid biopsy sensitivity gan Tang, Yong, Liu, Xianling, Ou, Zhu'An, He, Zhe, Zhu, Qihang, Wang, Ye, Yang, Mei, Ye, Junyi, Han-Zhang, Han, Qiao, Guibin

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients gan Lin, Quan, Zhang, Haoran, Ding, Huaxin, Qian, Jun, Lizaso, Analyn, Lin, Jing, Han-Zhang, Han, Xiang, Jianxing, Li, Yuping, Zhu, Hong

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer gan Mo, Shaobo, Ma, Xiaoji, Li, Yaqi, Zhang, Long, Hou, Ting, Han-Zhang, Han, Qian, Juanjuan, Cai, Sanjun, Huang, Dan, Peng, Junjie

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Targeted Sequencing Analysis of Predominant Histological Subtypes in Resected Stage I Invasive Lung Adenocarcinoma gan Li, Yan, Tan, Yan, Hu, Song, Xie, Jun, Yan, Zhantao, Zhang, Xian, Zong, Yun, Han-Zhang, Han, Li, Qing, Li, Chong

Cael y testun llawn Cael y testun llawn Cael y testun llawn

IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple ascending dose... gan Ji, Linong, Jiang, Hongwei, An, Pei, Deng, Huan, Liu, Meng, Li, Li, Feng, Liqi, Song, Baili, Han-Zhang, Han, Ma, Qingyang, Qian, Lei

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Comparison of genomic landscapes of large cell neuroendocrine carcinoma, small cell lung carcinoma, and large cell carcinoma gan Zhou, Zhen, Zhu, Lei, Niu, Xiaomin, Shen, Shengping, Zhao, Yi, Zhang, Jie, Ye, Junyi, Han‐Zhang, Han, Liu, Junjun, Liu, Chenglin, Lu, Shun

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Parallel serial assessment of somatic mutation and methylation profile from circulating tumor DNA predicts treatment response and impending disease progression in osimertinib-treat... gan Xia, Shu, Ye, Junyi, Chen, Yu, Lizaso, Analyn, Huang, Le, Shi, Lei, Su, Jing, Han-Zhang, Han, Chuai, Shannon, Li, Lingling, Chen, Yuan

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor gan He, Junjun, Ouyang, Wei, Zhao, Wugan, Shao, Lin, Li, Bing, Liu, Bihao, Wang, Dejuan, Han-Zhang, Han, Zhang, Zhou, Shao, Liang, Li, Wencai

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients gan Xiong, Liwen, Lou, Yuqing, Bai, Hao, Li, Rong, Xia, Jinjing, Fang, Wentao, Zhang, Jie, Han-Zhang, Han, Lizaso, Analyn, Li, Bing, Gu, Aiqin, Han, Baohui

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Liquid biopsy in extranodal NK/T-cell lymphoma: a prospective analysis of cell-free DNA genotyping and monitoring gan Qi, Fei, Cao, Zheng, Chen, Bo, Chai, Yue, Lin, Jing, Ye, Junyi, Wei, Yuce, Liu, Hao, Han-Zhang, Han, Mao, Xinru, Feng, Xiaoli, Dong, Mei

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Mutational landscape and clonal diversity of pulmonary adenoid cystic carcinoma gan Li, Min, Zhao, Bing-Rong, Liu, Shi-Qing, An, Jian, Deng, Peng-Bo, Han-Zhang, Han, Ye, Jun-Yi, Mao, Xin-Ru, Chuai, Shao-Kun, Hu, Cheng-Ping

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer gan Xiao, Weikai, Zhang, Guochun, Chen, Bo, Chen, Xiaoqing, Wen, Lingzhu, Lai, Jianguo, Li, Xuerui, Li, Min, Liu, Hao, Liu, Jing, Han-Zhang, Han, Lizaso, Analyn, Liao, Ning

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Mutational Landscape of PI3K-AKT-mTOR Pathway in Breast Cancer: Implications for Targeted Therapeutics gan Xiao, Weikai, Zhang, Guochun, Chen, Bo, Chen, Xiaoqing, Wen, Lingzhu, Lai, Jianguo, Li, Xuerui, Li, Min, Liu, Hao, Liu, Jing, Han-Zhang, Han, Lizaso, Analyn, Liao, Ning

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes gan Jiang, Hongwei, Pang, Shuguang, Zhang, Yawei, Yu, Ting, Liu, Meng, Deng, Huan, Li, Li, Feng, Liqi, Song, Baili, Han-Zhang, Han, Ma, Qingyang, Qian, Lei, Yang, Wenying

Cael y testun llawn Cael y testun llawn Cael y testun llawn